It is getting a bit quiet with PromarkerD, I grow a tad nervous as each day passes.
Another SGLT2-inhibitor drug completed a successful trial:
https://www.reuters.com/article/us-astrazeneca-study/astrazeneca-scores-win-as-diabetes-drug-shown-to-slow-kidney-disease-idUSKBN21H0KY
AstraZeneca’s diabetes treatment Farxiga has proven to be “overwhelmingly” effective at slowing chronic kidney disease ahead of the scheduled end of a drug trial, the British drugmaker said
Regarding Janssen presentation this weekend., page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.010(3.08%) |
Mkt cap ! $53.14M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.5¢ | 31.5¢ | $84.55K | 256.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27220 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 51171 | 2 |
View Market Depth
| Last trade - 11.53am 25/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |